These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33766512)

  • 1. In-Depth Analysis of the Hidradenitis Suppurativa Serum Proteome Identifies Distinct Inflammatory Subtypes.
    Navrazhina K; Garcet S; Gonzalez J; Grand D; Frew JW; Krueger JG
    J Invest Dermatol; 2021 Sep; 141(9):2197-2207. PubMed ID: 33766512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression.
    Navrazhina K; Garcet S; Zheng X; Hur HB; Frew JW; Krueger JG
    J Allergy Clin Immunol; 2022 Jan; 149(1):135-144.e12. PubMed ID: 34081946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa.
    Sabat R; Šimaitė D; Gudjonsson JE; Brembach TC; Witte K; Krause T; Kokolakis G; Bartnik E; Nikolaou C; Rill N; Coulibaly B; Levin C; Herrmann M; Salinas G; Leeuw T; Volk HD; Ghoreschi K; Wolk K
    J Allergy Clin Immunol; 2023 Apr; 151(4):1015-1026. PubMed ID: 36481267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa.
    Navrazhina K; Frew JW; Gilleaudeau P; Sullivan-Whalen M; Garcet S; Krueger JG
    J Allergy Clin Immunol; 2021 Jun; 147(6):2213-2224. PubMed ID: 33548397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum.
    Navrazhina K; Frew JW; Grand D; Williams SC; Hur H; Gonzalez J; Garcet S; Krueger JG
    Br J Dermatol; 2022 Aug; 187(2):223-233. PubMed ID: 35191018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa.
    Saraç Öztürk G; Ergun T; Peker Eyüboğlu İ; Akkiprik M
    Cytokine; 2021 Aug; 144():155585. PubMed ID: 34034145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris.
    Navrazhina K; Garcet S; Frew JW; Zheng X; Coats I; Guttman-Yassky E; Krueger JG
    J Am Acad Dermatol; 2022 Feb; 86(2):322-330. PubMed ID: 34339761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adalimumab on T-helper-17 lymphocyte- and neutrophil-related inflammatory serum markers in patients with moderate-to-severe hidradenitis suppurativa.
    Jiménez-Gallo D; de la Varga-Martínez R; Ossorio-García L; Collantes-Rodríguez C; Rodríguez C; Linares-Barrios M
    Cytokine; 2018 Mar; 103():20-24. PubMed ID: 29289722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa.
    Wolk K; Brembach TC; Šimaitė D; Bartnik E; Cucinotta S; Pokrywka A; Irmer ML; Triebus J; Witte-Händel E; Salinas G; Leeuw T; Volk HD; Ghoreschi K; Sabat R
    Br J Dermatol; 2021 Jul; 185(1):164-176. PubMed ID: 33400270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with hidradenitis suppurativa carry a higher systemic inflammatory load than other dermatological patients.
    Riis PT; Søeby K; Saunte DM; Jemec GB
    Arch Dermatol Res; 2015 Dec; 307(10):885-9. PubMed ID: 26350517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations to the Hidradenitis Suppurativa Serum Proteome with Spleen Tyrosine Kinase Antagonism: Proteomic Results from a Phase 2 Clinical Trial.
    Flora A; Jepsen R; Pham J; Frew JW
    J Invest Dermatol; 2024 Apr; 144(4):786-793.e1. PubMed ID: 37879397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.
    Vossen ARJV; Ardon CB; van der Zee HH; Lubberts E; Prens EP
    Br J Dermatol; 2019 Aug; 181(2):314-323. PubMed ID: 30657173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophils in hidradenitis suppurativa patients exhibit pro-inflammatory traits, implicating a potential pathogenic role in the disease.
    Renert-Yuval Y; Gonzalez J; Garcet S; Williams SC; Moreno A; Krueger JG
    Exp Dermatol; 2024 Jul; 33(7):e15129. PubMed ID: 38984465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.
    Kelly G; Hughes R; McGarry T; van den Born M; Adamzik K; Fitzgerald R; Lawlor C; Tobin AM; Sweeney CM; Kirby B
    Br J Dermatol; 2015 Dec; 173(6):1431-9. PubMed ID: 26282467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of interleukin-17 in the pathogenesis of hidradenitis suppurativa.
    Yao Y; Thomsen SF
    Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa.
    Gamell C; Bankovacki A; Scalzo-Inguanti K; Sedgmen B; Alhamdoosh M; Gail E; Turkovic L; Millar C; Johnson L; Wahlsten M; Richter J; Schuster J; Dyson A; Nicolopoulos J; Varigos G; Ng M; Wilson N; Field J; Kern JS; Lindqvist LM
    Br J Dermatol; 2023 Apr; 188(5):636-648. PubMed ID: 36691791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tunnels in Hidradenitis Suppurativa: Active Inflammatory Entities with Specific Molecular and Genetic Profiles - A Narrative Review.
    Krajewski PK; Szepietowski JC; Martorell A
    Dermatology; 2023; 239(3):323-327. PubMed ID: 36822156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils.
    Narla S; Azzam M; Townsend S; Vellaichamy G; Marzano AV; Alavi A; Lowes MA; Hamzavi IH
    Br J Dermatol; 2021 Jun; 184(6):1004-1013. PubMed ID: 32893875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Proinflammatory Leukotriene B4.
    Penno CA; Jäger P; Laguerre C; Hasler F; Hofmann A; Gass SK; Wettstein-Ling B; Schaefer DJ; Avrameas A; Raulf F; Wieczorek G; Lehmann JCU; Loesche C; Roth L; Röhn TA
    J Invest Dermatol; 2020 Dec; 140(12):2421-2432.e10. PubMed ID: 32387270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa.
    Mozeika E; Pilmane M; Nürnberg BM; Jemec GB
    Acta Derm Venereol; 2013 May; 93(3):301-4. PubMed ID: 23096596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.